Tag: Acute ischemic stroke

A Phase II, Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in Subjects with Acute Ischemic Stroke (AIS) (BRIGHT)

We are pleased to announce the 5th annual Stroke Survivor and Caregiver Event, hosted by the UNC & REX Comprehensive Stroke Centers. Bringing together stroke survivors, caregivers, healthcare professionals, and community partners for a day of learning, support, and connection!

Chapel Hill, N.C. — Researchers from UNC Neurology have published two studies that address critical questions in stroke management and post-neurocritical care, offering insights that could reshape clinical practice and improve patient outcomes. Study 1: Rethinking ICU Admission After Mechanical Thrombectomy The first study, “Resource Utilization After Mechanical Thrombectomy: Is...